| [1] | Yan CHAI, Tao ZHANG, Yinke FAN, Aiwu HUI, Lintao ZHAO, Fang LI, Xiaoli ZHANG. Effect of Yangxue Rougan pills on the TGF-β1/Smad signaling pathway in a rat model of liver fibrosis induced by multiple factors[J]. Journal of Clinical Hepatology, 2022, 38(9): 2040-2045. doi: 10.3969/j.issn.1001-5256.2022.09.018 |
| [2] | YUSUFUKADIER·Maimaitinijiati, AIMAITI·Yasen, Li WenDing, Ran Bo, TUERGANAILI.aji, Shao YingMei, Wen Hao. Effect of the transforming growth factor-β1 signaling pathway in inducing the differentiation of hepatic progenitor cells[J]. Journal of Clinical Hepatology, 2020, 36(3): 620-623. doi: 10.3969/j.issn.1001-5256.2020.03.030 |
| [3] | An BaiQuan, Xin YongNing, Lu LinLin, Xuan ShiYing. Effect of PNPLA3 I148M mutation on expression of TGF- β1 in rat hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 769-771. doi: 10.3969/j.issn.1001-5256.2016.04.035 |
| [4] | Gao HuiXia, Liu YuZhen, Lu JianHua, Ye LiHong, Dai ErHei. Correlation of Foxp3 + Tregs and TGFβ1 expression with inflammation in livers of patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(12): 952-955. |
| [5] | Zheng SuJun, Xing XinYue, Wu JuShan, Wang ShiMei, Zhang Ying, Han YuanPing, Yu Hao, Chen Yu, Liu Mei, Duan ZhongPing. ShRNA targeted to rat Smad3 decreases the profibrosis role of TGFβ1 in HSC-T6 cells[J]. Journal of Clinical Hepatology, 2012, 28(4): 289-295. |
| [6] | Hu TaiHong, Jiang XiangHu, Jiang YueMing, Zhou Min, Xu Min, Zhu Rui, Yang Ling. Expression of NF-κB and ERK-1mRNA in rat with liver fibrosis[J]. Journal of Clinical Hepatology, 2009, 25(1): 23-25. |
| [7] | Kang HaiYan, Dong JiangLong, Ye LiHong, Wang JianBin, Liu Lian, Yin ShuYing. Relationship between the expression of BFGF/TGF-β1 in liver tissue and liver fibrosis/inflammation in 260 patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(2): 97-99. |
| [9] | Kang HaiYan, Dong JiangLong, Wang JianBin, Li BingShun, Zhang HongXia. Relationship between transforming growth factor β1 and liver fibrosis and liver function in 260 patients with hepatitis B [J]. Journal of Clinical Hepatology, 2009, 25(1): 61-62. |
| [10] | Xu TingTing, Jiang MiaoNa, Jia YuJie, Che Ying. Ganfukang's effect on transforming growth factor β1 and laminin of experimental liver fibrosis rats[J]. Journal of Clinical Hepatology, 2005, 21(1): 30-31. |
| [11] | Ling YunFeng, Feng ZhenBo, He RuKun, Lu: ZiLi. Expression of TGFβ1、TGFβRⅠ and TGFβRⅡ in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2005, 21(1): 35-37. |
| [12] | Ma HongBo, Lang ZhenWei, Huang DeZhuang, Yan HuiPing, Luo ChaoXia. Study on transfusion transmitted virus in liver tissue of people with no viral hepatitis by the method of in situ hybridization.[J]. Journal of Clinical Hepatology, 2004, 20(5): 277-278+321. |
| [13] | Bi Qing, Cheng Lei, Cui LiAn, Zhang JunFu. The effect of Kangxianruanjian on TGF β1 and it's the recepters in liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2002, 18(3): 181-182. |
| [14] | Li QingHua, Li Hui, Qin ChengYong, Han GuoQing. The significance of urine transforming growth factor-β1 (TGF-β1) and serum procollagen type Ⅲ (PCⅢ) , collagen type Ⅳ (Ⅳ-C) , hyaluronic (HA) and laminin (LN) in patient with chronic HBV related liver disease[J]. Journal of Clinical Hepatology, 2001, 17(3): 161-162. |
| [15] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |
DownLoad: